Source: EURLEX
Language: en
Format: md

|  |  |  |  |
| --- | --- | --- | --- |
| 31.10.2022 | EN | Official Journal of the European Union | C 418/54 |

---

Action brought on 20 September 2022 — Trus v EUIPO — Unilab (ARTRESAN)

(Case T-585/22)

(2022/C 418/69)

Language in which the application was lodged: English

Parties

Applicant: Mariusz Trus (Lublin, Poland) (represented by: W. Włodarczyk, lawyer)

Defendant: European Union Intellectual Property Office (EUIPO)

Other party to the proceedings before the Board of Appeal: Unilab LP (Rockville, Maryland, United States)

Details of the proceedings before EUIPO

Proprietor of the trade mark at issue: Other party to the proceedings before the Board of Appeal

Trade mark at issue: European Union word mark ARTRESAN — European Union trade mark No 4 304 937

Procedure before EUIPO: Cancellation proceedings

Contested decision: Decision of the First Board of Appeal of EUIPO of 20 July 2022 in joined Cases R 1428/2020-1 and R 1481/2020-1

Form of order sought

The applicant claims that the Court should:

|  |  |
| --- | --- |
| — | annul the contested decision to the extent that the trade mark at issue was maintained for the goods in Class 5 ‘therapeutic creams for joints; food supplements for medical purposes’; |

|  |  |
| --- | --- |
| — | declare the mark revoked also for the above mentioned goods in Class 5; |

|  |  |
| --- | --- |
| — | order EUIPO and the intervener to pay the costs incurred in the present proceedings and in the proceedings before the Board of Appeal. |

Pleas in law

|  |  |
| --- | --- |
| — | Infringement of Article 58(1)(a) of Regulation (EU) 2017/1001 of the European Parliament and of the Council; |

|  |  |
| --- | --- |
| — | Infringement of the first sentence of Article 94(1) of Regulation (EU) 2017/1001 of the European Parliament and of the Council. |

---

[Top](#document1)